One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry

Authors :: Bente Glintborg
Sørensen, I. J.
Omerovic, E.
Mehnert, F.
Manilo, N.
Kamilla Danebod
Jensen Dorte Vendelbo
Henrik Nordin
Anne Gitte Loft
Oliver Hendricks
Chrysidis, S.
Andersen, B. L.
Johnny Lillelund Raun
Hanne Merete Lindegaard
Jakob Espesen
Jakobsn, S. H.
Inger Marie Jensen Hansen
Dalsgaard, E. B.
Krogh, N.
Merete Lund Hetland
Source :: University of Southern Denmark, Glintborg, B, Sørensen, I J, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Dorte Vendelbo, J, Nordin, H, Loft, A G, Hendricks, O, Chrysidis, S, Andersen, B L, Lillelund Raun, J, Lindegaard, H M, Espesen, J, Jakobsn, S H, Jensen Hansen, I M, Dalsgaard, E B, Krogh, N & Hetland, M L 2018, ' One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry ', EULAR 2018, Amsterdam, Netherlands, 13/06/2018-16/06/2018 .

Database :: OpenAIRE
Journal :: University of Southern Denmark, Glintborg, B, Sørensen, I J, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Dorte Vendelbo, J, Nordin, H, Loft, A G, Hendricks, O, Chrysidis, S, Andersen, B L, Lillelund Raun, J, Lindegaard, H M, Espesen, J, Jakobsn, S H, Jensen Hansen, I M, Dalsgaard, E B, Krogh, N & Hetland, M L 2018, ' One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry ', EULAR 2018, Amsterdam, Netherlands, 13/06/2018-16/06/2018 .
Accession number :: edsair.dedup.wf.001..9e41342c39b0b58cad04e8a6a53bd43e

Tools